- Relapse of acute myeloid leukemia after allogeneic stem cell transplantation: immune escape mechanisms and current implications for therapy
Tatjana Sauerer et al, 2023, Molecular Cancer CrossRef - Bispecific anti-CD3Ă—anti-CD155 antibody mediates T-cell immunotherapy in human haematologic malignancies
Li Ma et al, 2023, Investigational New Drugs CrossRef - Role of Biomarkers in FLT3 AML
null Nitika et al, 2022, Cancers CrossRef - Overcoming tumor resistance mechanisms in CAR-NK cell therapy
Antonio Valeri et al, 2022, Frontiers in Immunology CrossRef - CD155 as an emerging target in tumor immunotherapy
Jiang-Wan Wu et al, 2024, International Immunopharmacology CrossRef - Therapeutic application of human type 2 innate lymphoid cells via induction of granzyme B-mediated tumor cell death
Zhenlong Li et al, 2024, Cell CrossRef - Immune checkpoints represent a promising breakthrough in targeted therapy and prognosis of myelodysplastic syndrome
Xinyu Guo et al, 2023, Heliyon CrossRef - Research Progress of B-Cell Lymphoma/Leukemia-2 Inhibitor Combined with Azacytidine in the Targeted Therapy of Acute Myeloid Leukemia
Yanyu Wang et al, 2022, Computational and Mathematical Methods in Medicine CrossRef - The role of exhausted natural killer cells in the immunopathogenesis and treatment of leukemia
Asal Barshidi et al, 2024, Cell Communication and Signaling CrossRef